XML 76 R52.htm IDEA: XBRL DOCUMENT v3.19.1
License, Collaboration and Other Significant Agreements - Revenues Recognized From License, Collaboration and Other Significant Agreements (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
License, Collaboration and Other Revenue:              
License, Collaboration and Other Revenue         $ 207,742,000 $ 181,227,000 $ 1,535,000
License, Collaboration and Other Revenue              
License, Collaboration and Other Revenue:              
License, Collaboration and Other Revenue $ 53,026,000 $ 53,169,000 $ 48,793,000 $ 45,930,000 200,918,000 181,227,000 1,535,000
License, Collaboration and Other Revenue | Mitsubishi Tanabe Pharma Corporation              
License, Collaboration and Other Revenue:              
License, Collaboration and Other Revenue         9,281,000 42,918,000  
License, Collaboration and Other Revenue | Otsuka Pharmaceutical Company. Ltd.              
License, Collaboration and Other Revenue:              
License, Collaboration and Other Revenue             1,500,000
License, Collaboration and Other Revenue | Otsuka Pharmaceutical Company. Ltd. | Development and Commercialize United States Collaboration and License Agreement              
License, Collaboration and Other Revenue:              
License, Collaboration and Other Revenue         103,870,000 85,971,000 1,535,000
License, Collaboration and Other Revenue | Otsuka Pharmaceutical Company. Ltd. | Development and Commercialize International Collaboration and License Agreement              
License, Collaboration and Other Revenue:              
License, Collaboration and Other Revenue         87,320,000 52,307,000  
License, Collaboration and Other Revenue | Mitsubishi Tanabe Pharma Corporation and Otsuka Pharmaceutical Company Limited              
License, Collaboration and Other Revenue:              
License, Collaboration and Other Revenue         200,471,000 181,196,000 $ 1,535,000
License, Collaboration and Other Revenue | Japan Tobacco Incorporation and Torii Pharmaceutical Company Limited              
License, Collaboration and Other Revenue:              
License, Collaboration and Other Revenue         112,000    
License, Collaboration and Other Revenue | Clinical and Regulatory Activities              
License, Collaboration and Other Revenue:              
License, Collaboration and Other Revenue         $ 335,000 $ 31,000